Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-007516
Filing Date
2025-12-04
Accepted
2025-12-04 16:18:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 12251
  Complete submission text file 0001959173-25-007516.txt   14004
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Reporting) CIK: 0001797409 (see all company filings)

EIN.: 842985609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39980 | Film No.: 251549594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)